{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.12.1265","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.196.12.1265/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1265","version":"eCQM Update 2020-05-07","name":"AromataseInhibitors","title":"Aromatase Inhibitors","status":"active","date":"2018-03-10","description":"(Clinical Focus: This value set contains concepts that represent aromatase inhibitor medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Active or Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; both steroidal and non-steroidal inhibitors; both non-selective and selective inhibitors; aromatase inhibitors only.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; aromatase inhibitors in combination with other medications; selective inhibitors vorozole, formestane, and fadrozole.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"2020-01","concept":[{"code":"199224","display":"anastrozole 1 MG Oral Tablet"},{"code":"200064","display":"letrozole 2.5 MG Oral Tablet"},{"code":"310261","display":"exemestane 25 MG Oral Tablet"}]}]}}